Skip to main content
. 2022 Jul 20;481(3):351–366. doi: 10.1007/s00428-022-03344-1

Fig. 4.

Fig. 4

Error rates in lung cancer biomarker analysis for EGFR, ALK, and ROS1 across EQA schemes run by the European Society of Pathology, 2012–2015 [58]. Figure adapted from Keppens et al. [58]. Copyright © 2021 The Authors. Published by Impact Journals. All rights reserved. Reproduced under the terms of Creative Commons Attribution 3.0 International (CC BY 3.0) license. ALK anaplastic lymphoma kinase, EGFR epidermal growth factor receptor, EQA external quality assessment, FISH fluorescent in situ hybridisation, IHC immunohistochemistry, ROS1 ROS proto-oncogene 1